| Literature DB >> 36157304 |
Patrick C Barrett1, Darren T Hackley2, Linsen T Samuel2, Peter J Apel2.
Abstract
Purpose: We provide a systematic review of the current literature regarding best practices in postoperative care following carpometacarpal arthroplasty, and compare these findings to current practices via reported survey data.Entities:
Keywords: CMC arthroplasty; Carpometacarpal joint; Hand therapy; Immobilization timeframe; Systematic review
Year: 2022 PMID: 36157304 PMCID: PMC9492801 DOI: 10.1016/j.jhsg.2022.05.011
Source DB: PubMed Journal: J Hand Surg Glob Online ISSN: 2589-5141
Health-Related Databases, Hits, and Search Terms and Methodology (conducted on July 19, 2021)
| Database | Hits | Search Terms and Methodology |
|---|---|---|
| PubMed | 2,901 | ((“trapezium bone/surgery”[MeSH Terms] OR “thumb/surgery”[MeSH Terms] OR “carpometacarpal joints/physiopathology”[MeSH Terms] OR “carpometacarpal joints/surgery”[MeSH Terms]) AND “english”[Language]) AND (english[Filter]) |
| Google Scholar | 334 | allintitle: “TMC arthroplasty” OR trapeziectomy OR “CMC arthroplasty” OR “ligament reconstruction AND tendon interposition” OR “Suture suspension arthroplasty” OR “carpometacarpal arthroplasty” |
| Cochrane | 282 | #1 CMC OR carpometacarp OR “basal joint” OR “basilar joint” OR thumb OR CMC-1 OR “thumb base” OR trapez OR trapeziometacarp OR basilar OR “carpometacarpal joint” OR “thumb joint” OR basilal OR TMC |
| ScienceDirect | 208 | (carpometacarp OR thumb OR basilar OR trapez) AND (arthroplasty OR “ligament AND reconstruction” OR LRTI OR trapeziectomy) |
| Cumulative Index to Nursing and Allied Health Literature (CINAHL) | 174 | AB (carpometacarpi OR thumb OR “thumb base” OR basilar OR basal OR CMC-1 OR CMC OR “basilar joint” OR trapez OR trapeziometacarp) AND AB (arthroplasty OR LRTI OR “ligament AND reconstruction” OR “tendon AND interposition” OR arthrodesis OR trapeziectomy OR pyrocarbon) |
AB, abstract; CMC-1, 1st carpometacarpal joint; MeSH, Medical Subject Headings; TMC, trapeziometacarpal.
Figure 1The PRISMA 2020 flow diagram of systematic review process and study selection.
Oxford Centre for Evidence-Based Medicine Levels of Evidence
| Level | Description |
|---|---|
| I | High-quality RCTs or systematic review of level-I RCTs |
| II | Prospective cohort studies or systematic review of level-II studies |
| III | Case-control study, retrospective study, or systematic review of level-III studies |
| IV | Case series or case report |
| V | Expert opinion or survey |
RCT, randomized controlled trial.
Characteristics of Included Randomized and Nonrandomized Studies
| Author (Y) | LOE | Sample Size & Demographics | Study Design | Surgical Intervention | Immobilization Duration | Postoperative Rehabilitation | Outcome Metrics and Timelines | Outcomes & |
|---|---|---|---|---|---|---|---|---|
| Tsehaie et al | III | Group A: n = 131; 74% female; mean age, 60. | Prospective cohort study with propensity score matching | Weilby procedure (shorter vs longer immobilization) | Group A: 0–3 to 5 days: plaster cast; 5 days to 4 wks: thumb-spica orthosis with wrist immobilization; 4–8 wks: thumb butterfly orthosis; 8–10 wks: orthosis phased out; 10 wks: orthosis discontinued. Group B: 0–10 to 14 days: plaster cast; 2–6 wks: thumb-spica orthosis with wrist immobilization; 6–8 wks: thumb butterfly orthosis; 8 wks to 3 mos: orthosis phased out; 3 mos: orthosis discontinued | Directly postop: tendon-gliding exercises of the fingers and thumb IP joint; 10–14 days: sutures removed; 2–6 wks: hand therapy and home exercises focusing on active wrist flexion/extension, CMC-1 palmar/radial abduction, MCP-1 flexion (with support of thumb), scar management. No flexion/adduction and thumb opposition allowed; 6 wks to 3 mos: initiation of static pinch, then increased grip and pinch exercises | Palmar abduction, radial abduction, MCP extension, MCP flexion; t0 = preop; t1 = 3 mos | Palmar abduction, group A: t0, 46°; t1, 44°; group B: t0, 46°; t1, 45°; radial abduction (A): t0, 53°; t1, 44°; (B): t0, 47°; t1, 47°; MCP extension (A): t0, −16°; t1, −8°; (B): t0, −16°; t1, −10°; MCP flexion (A): t0, 64°; t1, 61°; (B): t0, 64°; t1, 60° |
| Hutchinson et al | II | n = 223; t = 238. Group A: n = 80; 62 F/18 M; 42 dom involved; 12 bilateral. Group B: n = 89; 70 F/19 M; 49 dom involved; 12 bilateral | Randomized controlled trial | Trapeziectomy with LRTI using FCR (rigid orthotic device vs semirigid orthotic device) | Group A: 0–7 days: forearm-based thumb-spica plaster orthosis; 1–6 wks: forearm-based thumb-spica cast; 6–12 wks: forearm-based thermoplastic thumb-spica orthosis; 12 wks: immobilization discontinued. Group B: 0–7 days: forearm-based thumb-spica orthosis; 1–4 wks: forearm-based thermoplastic thumb-spica orthosis; 4–8 wks: hand-based thumb-spica orthosis; 8 wks: immobilization discontinued | 1-wk office visit: ice, elastic garments, electrical stimulation (on occasion) as needed for edema control. Group A: 6 wks: AROM; 12 wks: resistive wrist strengthening, thumb strengthening with putty. Group B: 4 wks: AROM; 8 wks: resistive wrist strengthening, thumb strengthening with putty | DASH, 9-hole peg test, VAS pain, VAS satisfaction, ROM wrist and thumb, grip strength, 2-point pinch, 3-point pinch, lateral pinch; preoperative, 6 wks, 12 wks, 26 wks, 52 wks, 104 wks. | No significant differences were found in DASH, VAS pain, or VAS satisfaction scores between any groups at any time point. All 3 measurements improved in both groups after surgery. No significant differences in pinch strength between groups at any time point. At 6 weeks postop, group B (early immobilization group) demonstrated better 9-hole peg test, thumb ROM, and wrist ROM than group A but these metrics, including grip strength, did not differ between groups at any other time point |
| Prosser et al | I | n = 56; t = 56; 45 F/11 M; age mean = 67.8; dominant thumb 27/56 | Randomized controlled trial | Trapeziectomy & LRTI using FCR (rigid vs semirigid immobilization) | 0 to 10–14 days: dorsal plaster backslab immobilizing wrist and thumb; 10–14 days to 6 wks. Group A: semirigid neoprene with bonded thermoplastic orthosis. Neoprene extended from thumb IP joint to distal two-thirds of forearm. Thermoplastic piece on radial aspect of thumb extended from midproximal phalanx to just below wrist, with thumb in maximal comfortable palmar abduction. Orthosis allowed approximately 60% to 70% of wrist extension/flexion, 5° to 25° MCP flexion, and 45° to 55° CMC palmar abduction and opposition to all fingertips. Group B: rigid, thermoplastic orthosis from thumb IP joint to distal two-thirds of the forearm, immobilizing MCP, CMC joints, and wrist (IP joint left free). Thumb in palmar abducted position and wrist in 30° extension. Allowed for no thumb MCP, CMC, or wrist joint motion. 6 wks: orthosis discontinued | 10–14 days: 10 repetitions, 4 times daily out of orthosis. Thumb IP flexion/extension, wrist flexion/extension. Wk 3: isolated thumb MCP flexion, extension to neutral only, instructed not to hyperextend MCP joint. Wk 4: CMC active palmar abduction. Light activity as tolerated, (lifting objects approximately 100 g). Wk 6: light activity without orthosis, scar management/massage; Wk 12: moderate to heavy activity. Hand therapy, monitored exercise weekly for first 4 weeks, then every other week for next 6 weeks. | PRWHE (total, pain, function), MHQ total, CMC palmar abduction, MCP extension, 3-point pinch; t0 = preop; t1 = 6 wks; t2 = 3 mos; t3 = 1 yr | |
| Poole et al | II | n = 9; t = 9; 8 F/1 M; mean age, 58.0 (range, 49–68); 4 dom/5 non | Randomized controlled trial | Partial trapeziectomy with suture suspensionplasty using PL and K-wire distraction | 0 to 10–14 days: bulky dressing and orthosis. 10–14 days: sutures removed; 3–4 wks: K-wires removed; 4 wks: thumb-spica or c-bar orthosis | Group A: 4 wks: OT visit, received home program consisting of information regarding orthosis wear, edema control methods, AROM, massage of the hand. Group B: 4 wks: OT for 1 hr, 1 time/week for 4 wks consisting of reduction of edema, instruction of ROM and strength exercises, and ADL. | CMC flexion, abduction, MCP flexion, grip strength (kgs), 2-point pinch (kgs), 3-point pinch (kgs), pegboard (s), Jebson total (s), AHFT applied dexterity (s), FSS, SSS, AIMS: hand and finger, arm, work, overall impact, total function; t0 = preop; t1 = 6 months | CMC flexion, group A: t0, 4.8, t1, 15.2; group B: t0, 10; t1, 16.25; Abduction (A): t0, 50; t1, 52; (B): t0, 48.75; t1, 44.5; MCP flexion (A): t0, 54; t1, 55; (B): t0, 47; t1, 46; Grip strength (A): t0, 24.9 kgs; t1, 22.9 kgs; (B): t0, 26.0 kgs; t1, 29.3 kgs; 2-point pinch (A): t0, 3.9 kgs; t1, 5.2 kgs; (B): t0, 3.7 kgs; t1, 5.2 kgs; 3-point pinch (A): t0, 5.6 kgs; t1, 5.3 kgs; (B): t0, 4.9 kgs; t1, 6.3 kgs; pegboard (A): t0, 20.0 s; t1, 19.7 s; (B): t0, 21.8 s; t1, 22.5 s; Jebson total (A): t0, 64.2 S; t1, 64.9 S; (B): t0, 68.4 S; t1, 59.5 S; AHFT applied dexterity (A): t0, 116 s; t1, 118.2 s; (B): t0, 122.6 s; t1, 121.5 s; FSS (A): t0, 2.9; t1, 1.7; (B): t0, 2.8; t1, 1.6; SSS (A): t0, 3.2; t1, 1.7; (B): t0, 3.3; t1, 1.5; AIMS hand and finger (A): t0, 5.9; t1, 1.2; (B): t0, 5.7; t1, 1.5; AIMS arm (A): t0, 2.7; t1, 1.4; (B): t0, 0.8; t1, 1.7; AIMS work (A): t0, 5.1; t1, 0.8; (B): t0, 6.3; t1, 2.1; AIMS overall impact (A): t0, 2; t1, 1; (B): t0, 2.5; t1, 0; AIMS total function (A): t0, 13.9; t1, 2.1; (B): t0, 14.6; t1, 5.3 |
| Horlock & Belcher | III | Group A: t = 20; 14 F/6 M; mean age, 58; 11 R/9 L; 9 dom/11 non. Group B: t = 20; 16 F/4 M; mean age, 59; 9 R/11 L; 11 dom/9 non | Prospective, randomized | Simple trapeziectomy (late vs early immobilization) | Group A: 0–1 wk: palmer scotchcast plus slab with wrist in slight extension and thumb in slight abduction and extension; 1–6 wks: customized orthosis used for heavier activities and at night. Group B: 0–2 wks: same palmer scotchcast plus slab; 2–4 wks: customized orthosis worn continuously: 4–6 wks: allowed out of orthosis | Group A: 1 wk: light use of thumb and exercises taught. Group B: 4 wks: gentle use and mobilization allowed out of the orthosis | IP ROM, MCP ROM, thumb abduction, thumb extension, Kapandji opposition, grip strength, pulp pinch, key pinch, SMD, TMD; VAS function, VAS pain, VAS movement; t0 = preop; t1 = median 6 mos (range, 6–8 mos) | IP ROM, group A: t0, 86; t1, 90; group B: t0, 82; t1, 86; MCP ROM (A): t0, 61; t1, 56; (B): t0, 66; t1, 57; abduction (A): t0, 4.0 cm; t1, 4.5 cm; (B): t0, 4.0 cm; t1, 4.5 cm; extension (A): t0, 3.5 cm; t1, 4 cm; (B): t0, 3 cm; t1, 4 cm; opposition (A): t0, 9; t1, 9; (B): t0, 9; t1, 9; grip strength (A): t0, 19 kg; t1, 24 kg; (B): t0, 15 kg; t1, 21 kg; pulp pinch (A): t0, 2.0 kg; t1, 3.1 kg; (B): t0, 1.7 kg; t1, 2.5 kg; key pinch (A): t0, 3.5 kg; t1, 4.3 kg; (B): t0, 3 kg; t1, 3.9 kg; SMD (A): t0, 10 mm; t1, 2 mm; (B): t0, 11 mm; t1, 3 mm; TMD (A): t0, 8 mm; t1, 0 mm; (B): t0, 7 mm; t1, 1 mm; VAS function (A): t0, 45; t1, 21; (B): t0, 44; t1, 25; VAS pain (A): t0, 61; t1, 18; (B): t0, 77; t1, 25; VAS movement (A): t0, 50; t1, 13; (B): t0, 50; t1, 16. |
ADL, activities of daily living; AHFT, Arthritis Hand Function Test; AIMS, Arthritis Impact Measurement Scales; CMC-1, 1st carpometacarpal joint; DASH, Disabilities of the Arm, Shoulder, and Hand; dom, dominant; FCR, flexor carpi radialis; FSS, Functional Status Scale; IP, interphalangeal; LOE, level of evidence; MCP, metacarpophalangeal; MCP-1, 1st metacarpophalangeal joint; MHQ, Michigan Hand Questionnaire; non, nondominant; OT, occupational therapy; PL, Palmaris Longus; postop, postoperative; preop, preoperative; PRWHE, Patient Rated Wrist/Hand Evaluation; SMD, minimum distance between the base of the thumb metacarpal and distal end of the scaphoid; SSS, Symptom Severity Scale; t, number of thumbs; TMD, minimum distance between the base of the thumb metacarpal and the radial border of the trapezoid; VAS, visual analog scale.
All scores for t1, t2, and t3 represent group A (semirigid) compared to group B (rigid). Negative scores indicate that group A performed worse than group B.
Characteristics of Included Cross-Sectional Survey Studies
| Author (Year) | Level of Evidence | Survey Type | Sample Size; Response Rate | Response Representation |
|---|---|---|---|---|
| Siegel et al | V | ASHT survey | 3,221; 19% | Nonresponse bias and inability to reach those therapists who treat postoperative CMC arthroplasty but are not CHTs or ASHT members. |
| Deutch et al | V | ASSH survey | 3,354; 25% | Possibility of recall bias and that it does not represent actual population, especially for international surgeons. |
| Brunton & Wilgis | V | ASSH survey | 2,536; 40% | Nonresponse bias and spam filters. Largest response rate of ASSH surveys at the time; however, unable to differentiate those still in training. |
ASHT, American Society for Hand Therapists; CHT, Certified Hand Therapist.
Figure 2Revised Cochrane risk-of-bias tool for randomized trials and the Risk of Bias in Nonrandomized Studies of Interventions assessment tool.
Figure 3Joanna Briggs Institute Critical Appraisal Checklist for Analytical, Cross-Sectional Studies. JBI, Joanna Briggs Institute.